Please login to the form below

Not currently logged in

lung cancer

This page shows the latest lung cancer news and features for those working in and with pharma, biotech and healthcare.

New dosing option for AZ’s Imfinzi approved in the EU and UK

New dosing option for AZ’s Imfinzi approved in the EU and UK

new dosing option in locally advanced, unresectable non-small cell lung cancer (NSCLC). ... The new dosing regimen is consistent with Imfinzi’s approved dosing in extensive-stage small cell lung cancer (ES-SCLC).

Latest news

More from news
Approximately 108 fully matching, plus 834 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 61 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 15 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....